Prostaglandin H2 Explained
Prostaglandin H2 (PGH2), or prostaglandin H2 (PGH2), is a type of prostaglandin and a precursor for many other biologically significant molecules. It is synthesized from arachidonic acid in a reaction catalyzed by a cyclooxygenase enzyme.[1] The conversion from arachidonic acid to prostaglandin H2 is a two-step process. First, COX-1 catalyzes the addition of two free oxygens to form the 1,2-dioxane bridge and a peroxide functional group to form prostaglandin G2 (PGG2).[2] Second, COX-2 reduces the peroxide functional group to a secondary alcohol, forming prostaglandin H2. Other peroxidases like hydroquinone have been observed to reduce PGG2 to PGH2.[3] PGH2 is unstable at room temperature, with a half life of 90-100 seconds,[4] so it is often converted into a different prostaglandin.
It is acted upon by:
It rearranges non-enzymatically to:
Functions of prostaglandin H2:
- regulating the constriction and dilation of blood vessels
- stimulating platelet aggregation
- binds to thromboxane receptor on platelets' cell membranes to trigger platelet migration and adhesion to other platelets.[5]
Effects of aspirin on prostaglandin H2:
- Aspirin has been hypothesized to block the conversion of arachidonic acid to prostaglandin
Notes and References
- van der Donk WA, Tsai AL, Kulmacz RJ . The cyclooxygenase reaction mechanism . Biochemistry . 41 . 52 . 15451–8 . December 2002 . 12501173 . 10.1021/bi026938h .
- Salomon. Robert G.. Miller. Donald B.. Zagorski. Michael G.. Coughlin. Daniel J. . vanc . October 1984 . Prostaglandin endoperoxides. 14. Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution. Journal of the American Chemical Society . 106. 20. 6049–6060. 10.1021/ja00332a049. 0002-7863.
- Hla T, Neilson K . Human cyclooxygenase-2 cDNA . Proceedings of the National Academy of Sciences of the United States of America . 89 . 16 . 7384–8 . August 1992 . 1380156 . 49714 . 10.1073/pnas.89.16.7384 . 1992PNAS...89.7384H . free .
- David S. Wishart. Showing metabocard for Prostaglandin H2 (HMDB0001381).
- Woodward DF, Jones RL, Narumiya S . International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress . Pharmacological Reviews . 63 . 3 . 471–538 . September 2011 . 21752876 . 10.1124/pr.110.003517 . free .